Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
Not available.*
Pioglitazone Hydrochloride Tablet
Product Images NDC 82009-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 82009-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (15 mg (30 Tablet Bottle))
Package Label-principal Display Panel (30 mg (500 Tablets Bottle))
This text appears to be the description and details of a medication called Pioglitazone Tablets, USP. Each tablet contains Pioglitazone hydrochloride USP equivalent to pioglitazone 30 mg. The usual dosage and administration information can be found in the accompanying literature. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture and humidity. The medication should be kept in a tightly closed, light-resistant container and out of reach of children. It should not be accepted if the seal over the bottle opening is broken or missing. The text also includes the date of issuance, number of tablets (500), NDC code, manufacturer information, and pharmacist instructions. The text does not provide any information on the specific medical condition that this medication is used for.*
Package Label-principal Display Panel (45 mg (500 Tablets Bottle))
Chemical Structure (Pioglitazone Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
